Azitra
Dr. Oh’s main research interests focus on the human microbiome—the diverse bacteria, fungi, and viruses that inhabit our bodies—for its potential to deliver treatments for infectious and other diseases. Dr. Oh comes to the microbiome world by way of fungal chemogenomics with technologist and geneticist Dr. Ronald Davis at Stanford and comparative genomics of wild wine yeast at the FAS Center for Systems Biology at Harvard. Prior to joining the Jackson Laboratory, she was a postdoctoral fellow at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health. Dr. Oh’s research, which has focused primarily on the skin microbiome, explores the complex interactions between the host and its microbes and has lead to important implications for the contribution of the microbiome to disease. Dr. Oh received a graduate degree from Stanford University (PhD) and undergraduate degree from Harvard University (BA).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Azitra
1 followers
Azitra, Inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications.